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ABSTRACT
THE RELATIONSHIP BETWEEN VITAMIN D STATUSES
AND YOUNG ADULT WOMEN ASTHMA
February, 2010
SHIYING BIAN, B.A., CAPITAL UNIVERSITY OF MEDICINE
M.A., UNIVERISITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Alayne Ronnenberg

Although maternal vitamin D status has been linked to asthma in offspring, the
relationship between vitamin D status and asthma in adults still remains unclear. The
current study assessed the relationship between measures of vitamin D status and selfreported asthma/wheeze in 186 healthy women aged 18-30 years. Although the risk of
asthma/wheeze symptoms was three-times higher among women with low dietary
vitamin D intake (<200 IU/day) than in those with higher vitamin D intake, suboptimal
serum levels of 25(OH)D ( <70 nmol/L) were associated with a 48% lower risk of
asthma/wheeze than ―optimal‖ serum levels. These contradictory effects underscore the
poor correlation between dietary vitamin D intake and serum vitamin levels and suggest
that other components in vitamin D-rich foods may be protective. Alternatively, women
with higher serum vitamin D levels may have spent more time outdoors, increasing their
exposure to asthma triggers. This study also identified predictors of serum 25 (OH) D in
this sample. In addition to total dietary vitamin D (r= 0.2; p=0.03), intake of cold cereal
(p=0.02) also significantly predicted serum 25(OH)D levels. Among non-dietary factors,
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month of blood draw (p=0.05) and oral contraceptive use (p<0.0001) were positive
predictors of serum 25(OH) D; sunscreen use (p=0.04) was a negative predictor. After
adjusting for covariates, oral contraceptive use was associated with 25(OH)D levels that
were on average 24 nmol/L greater than those observed in women who did not use oral
contraceptives. Additional prospective studies are needed to further evaluate the
relationship between vitamin D status and asthma.
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CHAPTER 1

INTRODUCTION

Although the role of vitamin D in bone health is well known, recent studies have
described new, nonskeletal roles for vitamin D in human health, including a role in
preventing chronic diseases such as cardiovascular disease, diabetes and cancer.
(Wang, 2008; Mohr, 2008; Holick, 2004a; Holick, 2004b)

In addition to these chronic diseases, vitamin D status may also be linked to
asthma, although this area of research is relatively new (Black, 2005, Burns 2006,
Camargo, 2007). Asthma is a common chronic lung disease that involves inflammation
of the pulmonary airways and bronchial hyper-responsiveness, which manifests as lower
airway obstruction (Expert Panel Report 3, 2007). Asthma is a common disease
worldwide and affects 22 million people in the United States alone. Although the overall
mortality rate for asthma has declined and asthma-related hospitalizations have
remained constant since 1995 (Centers for Disease Control and Prevention asthma
surveillance data; Moorman 2007), asthma nonetheless contributes substantially to
morbidity. Children and African Americans are especially affected by asthma; the
prevalence of asthma is twice as high in these groups as in other groups (Centers for
Disease Control and Prevention asthma surveillance data; Moorman 2007). The cost of
treating asthma continues to be a large burden in health care costs for both adults and
children.
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The prevalence of asthma increased throughout the late 1980s in developed
countries, leading to many hypotheses that attempted to explain this increase. One
hypothesis, the ―hygiene hypothesis,‖ suggested that declining family size reduced
exposure to infectious pathogens in early childhood, and higher standards of cleanliness,
compromise development of immune function which then increases susceptibility to
allergic diseases (Strachan, 1989), including asthma. Although this phenomenon may
account for some of the increase in asthma prevalence, it does not completely explain
the asthma epidemic. Other factors, including urban poverty (Platts-Mills, 2001), obesity
(Ford, 2005) and dietary components also appear to play a role (Raviv, 2010).

Litonjua and Weiss (2007) recently offered a new hypothesis to explain the
asthma epidemic. They hypothesized that vitamin D status influences asthma risk,
although they had direct evidence of a relationship only among pregnant women and
their offspring. Whether vitamin D status is associated with adult asthma remains
unclear. The main goal of the current project is to assess the relationship between
vitamin D status and asthma in young adult women.
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CHAPTER 2

ASTHMA

The term "asthma" comes from the ancient Greek language; it means ―to breathe
hard." Current medical terminology defines this condition as the reversible obstructive
airway disease (ROAD). ―Asthma is a chronic lung air way disorder, characterized by
episodic and reversible airflow obstruction, bronchial hyper- responsiveness and
underlying inflammation‖ (Expert Panel Report 3, 2007).The symptoms are highly
variable both among and within patients, ranging from mild illness to death. Clinical
manifestations include wheezing, coughing, and shortness of breath (Expert Panel
Report 3, 2007). Asthma can resolve spontaneously or require treatment.

According to the Center for Disease Control and Prevention data, from 1980 to
2004, the prevalence of asthma continued increasing in the United States. Asthma
increased in prevalence during 1980-1996, but since 1997 no discernable change has
been identified in asthma attack estimates. The overall prevalence of asthma in the
general population was about 7% in 2006. For the three-year period 2001-2003, 20
million people annually had diagnosed asthma in the United States. Of these,
approximately 6.2 million were children (aged <18 years) and 13.8 million were adults.
Approximately 2 million persons were aged >65 years. Overall mortality rates have
declined and hospitalizations have remained constant since 1995 due to advances in
diagnosis and treatment. The incidence of asthma is greater in children of all races as
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well as in African-Americans. Among children under the age of 10, asthma affects twice
as many boys as girls. But with increasing age, women are more likely to have asthma
compared to men (Stachan, 1996). Half of all cases first occur in children younger than
age 10. There are no clear explanations to explain the differentiations occur in age and
gender.

No single instrument can be used to identify asthma with certainty. Asthma is a
clinical diagnosis made by physicians on the basis of a patient‘s medical history,
physical examination, assessment of reversibility of airway obstruction and exclusion of
alternative diagnoses that can mimic asthma (EPR 3, 2007). Since each physician has a
different diagnosis level, this causes difficulty in asthma research and data collection.
Sometimes changes in asthma prevalence can be at least partly attributable to
subjective changes in diagnostic labeling.

The Pathophysiology of Asthma
The pathophysiology of asthma is complex and involves three main
characteristics: inflammation, reversible airway obstruction and bronchial hyperresponsiveness. (Busse, 2001)

Inflammation
Inflammation plays the central role in development and expression of asthma.
Inflammation not only causes the airway obstruction, but also contributes to airway
hyper-responsiveness, which enhances susceptibility to bronchospasm. The model that
infections could trigger and aggravate asthma in already sensitized individuals has been
well established. (Cohn, 2004).
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Inflammation in asthma is the result of a complex process that involves the
participation of different cell types in various tissues comprising the respiratory tract. The
cellular profile and the response of structural cells in asthma are quite consistent
regardless of differences in asthma presentation. Some of the principal cells identified in
airway inflammation include mast cells, eosinophils, epithelial cells, macrophages, and
activated T lymphocytes. T lymphocytes play the most important role in the regulation of
airway inflammation because they release numerous cytokines that regulate immune
function (Roberto, 2006; Busse, 1996).

The pattern of inflammation with viral infections and its effect on asthma are
distinct from that associated with allergen activation. Exposure to allergens causes
airway eosinophilic responses that are the end step controlled by the T cell immune
response, whereas viral infections elicit neutrophilic responses (Abu-Harb, 1999;
Pizzichini, 1998)

The presence and absence of infections may explain variation over time in
susceptibility to asthma in an individual. The chronic inflammation causing airway
remodeling in some patients may be associated with permanent alterations in the airway
structure (Buss, 2001). This can lead to more severe asthma later in life.

Bronchial hyperresponsiveness
Airway hyper-responsiveness is an exaggerated response to both exogenous and
endogenous stimuli. It leads to clinical symptoms, airway narrowing and subsequent
interference with airflow. The mechanisms involved include direct stimulation of airway
smooth muscle and indirect stimulation by physiologically active substances from
mediator-secreting cells, such as mast cells (Hargreave, 1981). Measurements of airway
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responsiveness appear to reflect the activity and severity of asthma at the time of
measurement rather than to define the prevalence of the illness over a specific period
(EPR3, 2007).

Reversible airway obstruction
Airflow obstruction can be caused by a variety of changes, including acute
bronchoconstriction, airway edema, airway hyper-responsiveness, and airway
remodeling (Finucane, 1985). Acute bronchoconstriction is the consequence of
immunoglobulin E–dependent mediator release following exposure to aeroallergens and
is the primary component of the early asthmatic response. Airway edema occurs 6-24
hours following an allergen challenge and is referred to as the late asthmatic response.
Airway hyper-responsiveness involves narrowing of the airway when exposed to stimuli,
such as food and medicine. Airway remodeling is associated with structural changes due
to long-standing inflammation and may profoundly affect airway obstruction. (Holgate,
2000)

Etiology (Pathogenesis)
Although the pathophysiology of asthma is fairly well understood, the exact
etiology of asthma is still not known. For many patients, the disease has its roots in
infancy. Both host factor and environmental factors influence the development and
exacerbation of asthma. Although environmental factors impact asthmatic conditions in
children, susceptibility to asthma is influenced by genetic factors as well (Holgate,
1999a).
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Host Factors
Genetics

Many genes have been found that either are involved in or linked

to the presence of asthma. Asthma is known as a "complex" heritable disease. This
means that there are a number of genes that contribute toward a person's susceptibility
to a disease. Researchers cannot find one exact gene that results in asthma; rather,
genes on chromosomes 5, 6, 11, 12, and 14 have all been implicated (Holgate, 1999a),
especially for allergen-induced asthma. According to the latest Expert Panel Report
(EPR) in 2007, the genetic predisposition for the development of an IgE-mediated
response to common aeroallergens is the strongest identifiable predisposing factor for
developing asthma."

Genetics may also contribute to asthma by influencing genes involved in immunity.
Airway inflammation in asthma may represent a loss of normal balance between two
populations of Th lymphocytes, Th1 and Th2. Th1 cells produce IL-2 and IFN-Ɣ, which
are critical in cellular defense mechanisms in response to infection. Th2 cells, in contrast,
generate a family of cytokines that can mediate allergic inflammation, and asthma is
characterized by a shift toward cytokine-like disease. Therefore this cytokine imbalance
toward Th2 is caused either by overexpression of Th2-type cytokines or
underexpression of Th1-type cytokines (Sundeep, 2001). This genetic background will
promote the production of antibody to key environmental antigens, and then increase an
individual‘s susceptibility to asthma (Larche, 2003).
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Sex

In early life, the prevalence of asthma is higher in boys, with a male-to-

female ratio of 2:1 until adolescence. After that time, asthma prevalence is greater in
females, and the majority of adult-onset cases diagnosed in persons who are older than
40 years occur in women (Fagan,2001).

Race

Asthma occurs in people of all races worldwide. In the United States,

asthma prevalence as well as its morbidity and mortality are higher in blacks than in
whites (ERP 3, 2007).

Environmental factors
Three environmental factors appear to be involved in the development and the
persistence of asthma. They do not work separately but interactively in the eventual
development of asthma.
Allergens

House dust mites, animal allergens (especially cat and

dog), cockroach allergens, and fungi are the most commonly reported allergens.
Sensitization and frequency of exposure to allergens are important factors in the
development of asthma in children (Busse, 2001; McConnell, 2002)).

Respiratory infections

Viral infections can exert influence on both

the development and the severity of asthma. They are an important cause of acute
wheezing in infancy, and viruses are detected in most exacerbations of asthma
throughout childhood. Furthermore, infants who develop severe viral respiratory
infections are more likely to have asthma later in childhood. (Pelaia,2006; Gern, 2002 ).
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Other environmental exposures Research has concluded that maternal
smoking can contribute to asthma or other impairment of infant lung function, even
before the child is born. Continued exposure to cigarette smoking can irritate the
respiratory tract and make infants and children particularly vulnerable to allergic asthma
(Ulrik, 2001).

It has been suggested that changes in dietary habits in recent years may
influence asthma development. Diets that are deficient in antioxidants such as vitamins
C and E may explain some of the rise in asthma and allergy prevalence (Weiss, 1997;
Romieu, 2001).

Epidemiologic studies have shown that the prevalence of obesity and that of
asthma are increasing together. The prevalence of asthma is higher in obese than lean
individuals (Ford, 2005). The reason for this association is still unknown. The possible
suggested mechanisms include reduced chest wall by obesity or immune function
change by obesity–related hormones (Shore, 2008).

Exposure to air pollution has also been associated with an increased risk for
onset of asthma, although the association is not as clear as the relationship between
allergens and respiratory infection (Peden, 2001).
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Classification of Asthma
Over the years, asthma has been classified using different classification schemes,
each of which has its own advantages and disadvantages. The most common
classification divides asthma into two general categories: extrinsic (allergic) asthma and
intrinsic (non-allergic) asthma, depending on the types of stimuli that trigger attacks
(Busse, 1996).

Extrinsic asthma (allergic asthma) Extrinsic asthma is a result of an
antigen\antibody reaction involving mast cells in the respiratory tract. The allergen is an
antigen that elicits IgE antibodies that are normally used to attack parasitic worms. This
allergen and antibody reaction causes the release of inflammatory mediators from mast
cells that elicit the clinical response associated with an asthma attack. Most childhood
asthma is considered an allergic type of asthma (Busse, 1996).

In allergic individuals, injection of protein just under the skin triggers an immediate
skin reaction, such as swelling or redness. An individual that has this type of reaction is
described as "atopic‖. Often extrinsic asthma is also called atopic or "allergic" asthma
(Holgate, 1999). People with allergic asthma and their families frequently have other
allergy-related problems. A positive family history of this type of reaction frequently
exists in patients with allergic asthma. Allergic asthma usually responds quite well to the
use of inhaled steroids, which suppress the immune system, particularly in the lungs
where the reaction is created (Holgate, 1999b).

Infants and young children have a high response to food allergies that produce
wheeze, but this response becomes much less frequent by the time the child reaches
age 10. From about 4 years of age, children develop allergies to inhaled substances,
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and this response may stay with the person for a lifetime. After young adulthood, allergic
reactions often decrease and so does the asthmatic response (Holgate, 1999b).

Intrinsic Asthma

Intrinsic asthma is not allergy-related. In fact, it can be

caused by substances that are not proteins. Possible causes of intrinsic asthma
symptoms include respiratory irritants such as perfumes, cleaning agents, fumes, smoke
and cold air, upper respiratory infections, and gastroesophageal reflux (GERD) (Holgate,
1999b)

Antibodies are not produced and antigen skin testing shows no reaction. With
intrinsic asthma, an asthmatics' airways are unusually sensitive or "hyper-reactive,‖ and
an attack may be triggered by an irritation to the nerves or muscles in the airways.
Despite the differences in triggers, both intrinsic and extrinsic asthma present with
similar symptoms. Intrinsic asthma is not likely to develop in children; its typical onset
occurs after age 40 (Buss, 2001). Prevention and treatment of intrinsic asthma are not
easy. Since it is difficult to identify the asthma triggers, avoiding those triggers can be
virtually impossible.

Symptoms and Diagnosis of Asthma
The common symptoms of an asthma episode include wheezing, chest tightness,
coughing, and shortness of breath, although these symptoms are present only some of
the time (Holgate, 1999b). Asthma is a clinical diagnosis made by physicians on the
basis of a patient‘s medical history, physical examination, assessment of reversibility of
airway obstruction and exclusion of alternative diagnoses that mimic asthma.
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In order to help treat asthma more effectively, in 1997 the National Heart, Lung
and Blood Institute identified four levels of asthma severity based on the frequency of
symptoms and exacerbations, effects on activity level, and lung function study results:
mild intermittent, mild persistent, moderate persistent, and severe persistent. This
classification is still used by most physicians.
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CHAPTER 3

VITAMIN D

Introduction
Vitamin D was first discovered in 1920 by Mellanby. It was originally described as
a ―vitamin‖ that is essential for normal skeletal development and maintenance of calcium
homeostasis in the body. With further research, it was discovered that vitamin D does
not strictly meet the definition of a vitamin since it can be synthesized in the body from
exposure to sunlight. Instead, vitamin D behaves more like a steroid hormone than a
vitamin, and its effects on health and disease depend on this hormonal action.

Vitamin D can be obtained from dietary sources or can be synthesized in the body.
Dietary vitamin D is available in two forms: vitamin D2 (ergocalciferol) from plant sources
and vitamin D3 (cholecalciferol) from animal sources, both of which are collectively called
vitamin D. However, dietary sources of vitamin D account for a very small amount of the
total vitamin D in the body since few foods naturally contain vitamin D. Most vitamin D
circulating in the bloodstream is synthesized in the skin from 7-dehydrocholesterol (7DHC) when it is exposed to ultraviolet B light. Vitamin D2 and vitamin D3 have only a
slight structural difference in their side chain. Neither vitamin form has biological activity;
both need to be activated to exert vitamin D-related effects.
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Figure 3.1 Structures of vitamin D2 and D3

Vitamin D2 (ergocalciferol)

Vitamin D3 (cholecalciferol)
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Sources of Vitamin D
Diet
As mentioned above, vitamin D is derived from two main sources: the diet and
cutaneous synthesis. Fatty fish and cod liver oil are among the few foods that naturally
contain vitamin D. In the U.S., milk and some dairy foods, juices and cereals are fortified
with vitamin D, although fortification is not common in other parts of the world. Vitamin D
is also available in supplements, either alone or with calcium and other nutrients (Holick,
2008). Table 3.1 lists the vitamin D content in various foods.

Table 3.1 Vitamin D Content of Selected Foods and Supplements
Source
Natural source
Salmon Fresh, wild( 3.5oz)
Fresh, farmed( 3.5oz)
Canned( 3.5oz)
Mackerel, canned( 3.5 oz)
Tuna, canned (3.6 oz)
Cod liver oil ( 1 tsp)
Shiitake mushrooms Fresh (3.5oz)
Sun-dried (3.5oz)
Fortified foods
Fortified milk ( 1 cup)
Fortified orange juice ( 1 cup)
Fortified yogurts( 1 cup)
Fortified breakfast cereals ( 1 cup)
Fortified butter ( 3.5oz)
Fortified cheese ( 3.5oz)
Supplements
Prescription vitamin D2
Prescription drisdol liquid supplements
Vitamin D3
Multivitamin
40 IU=1 ug vitamin D3

Vitamin D content (IU)
600-1000
100-200
300-600
250
230
400-1000
100
1600
100
100
100
100
50
100
50,000
8000
400,900,1000,2000
400
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Cutaneous synthesis of vitamin D
Because few foods contain vitamin D, most of the vitamin in circulation is derived
from cutaneous synthesis. Humans (and most animals) can synthesize vitamin D in the
skin when it is exposed to ultraviolet radiation. Solar ultraviolet B radiation (wavelength
between 290 to 315 nm) causes 7-dehydrocholesterol to isomerize to previtamin D 3,
which at body temperature thermally isomerizes to vitamin D 3. The whole isomerization
procedure may require one hour to days to produce vitamin D3. In ideal conditions,
nearly 3000 IU of vitamin D can be synthesized cutaneously following an average of 5 to
10 minutes of UVB exposure of the arms and legs. Excess exposure to sunlight will not
cause toxicity since solar UV radiation will degrade the extra previtamin D3 and vitamin
D3 into inactive photoproducts (Holick, 2004).

Numerous factors influence cutaneous vitamin D synthesis. First, only a narrow
range of wavelengths (290-315 nm ultraviolet B) can stimulate cutaneous synthesis.
Consequently, any geographical area above a latitude of 37 degrees in the northern
hemisphere or below 37 degrees in the southern hemisphere does not receive the
appropriate wavelength of ultraviolet B during the winter months ( such as November
through February in the Boston area ), since most UV-B is absorbed by the ozone layer
at that period. Therefore, vitamin D is not synthesized during winter. Second, public
health messages concerning the association between sun exposure and skin cancer has
led to widespread use of sunscreens. However, any sunscreen with a skin protection
factor (SPF) of 8 or more inhibits vitamin D synthesis by absorbing UV-B radiation.
Melanin in skin also inhibits cutaneous vitamin D synthesis, and dark skinned persons
need up to 10 times as much sun exposure as lightly pigmented persons to synthesize
an equivalent amount of vitamin D3. Third, clothing can also impede vitamin D synthesis,
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and women in some parts of the world who wear veils and other concealing clothing for
cultural reasons have a limited ability to obtain vitamin D by cutaneous synthesis ( Holick,
2007).

Metabolism of Vitamin D
Vitamin D3 and Vitamin D2 from dietary sources or cutaneous synthesis are
transported together to the venous circulation by the lymphatic system. In the circulation,
it binds to the vitamin D binding protein (DBP), which transports the vitamin to target
cells for metabolism. In the liver, vitamin D is converted by the enzyme 25-hydroxylase
to 25-hydroxyvitamin D3 [25(OH)D], which is the main circulating form of the vitamin D.
However, 25(OH)D remains biologically inactive until it is further hydroxylated to
1,25(OH) 2D3 (also known as calcitriol), the active form of the vitamin, by 1α–hydroxylase,
which is found primarily in the kidney . Calcitriol then generates biological responses in
over 30 target tissues. Activation of vitamin D is outlined in Figure 3.2
Figure 3.2 Synthesis of calcitriol
Cited from Mineral mechanism in nephropal .com
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Calcitriol works as a switch that can turn genes ―on‖ or ―off.‖ The vitamin D
receptor (VDR) works as a transcription factor inside the cell. Once bound by calcitriol,
the activated VDR binds to a companion protein, the retinoid-x receptor (RXR), forming a
heterodimer that binds to a specific region of the cell‘s DNA near to the target gene.
Attachment of the heterodimer to the DNA induces the cellular machinery to begin
transcribing the nearby gene into mRNA that the cell will translate into a protein. By
causing a cell to make a particular protein, calcitrol alters cellular function, and this ability
to trigger gene activity in different cells is the basis of vitamin D‗s physiological effect
(Norman et al, 2001; Figure 3.2)

At least 1000 different genes are
believed to be regulated by 1,25(OH) 2D3,
including several involved in vitamin D‘s
traditional role in calcium and bone
metabolism and other newly identified
roles in other conditions. (Tavera, 2007)

Figure 3.3 Mechanism of Vitamin D
Activity in Cell
Cited from Parathyroid Hormone in nephropal .com

Although most 25-hydroxylase activity is located in the liver, the enzyme is also
found in substantially lower quantities in the intestine, adrenal gland, lung, kidney and
bone. In addition, although circulating levels of 1,25(OH)2 D are the result of renal 1α–
hydroxylation, calcitriol is also synthesized ―locally‖ by 1α-hydroxylases in colon, breast,
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prostate, lung, activated macrophages and parathyroid (Holick, 2004). Calcitriol
produced by the kidney functions as an endocrine hormone, regulating serum calcium
concentrations, while locally produced calcitriol acts in an autocrine and paracrine
manner, specifically with respect to cell differentiation (Lips, 2006).

Physiologic Role of Calcitriol
Calcium homeostasis and bone metabolism
The endocrine hormone role of vitamin D on calcium homeostasis is the first
discovered function of vitamin D. Plasma calcium concentrations are usually tightly
maintained between 8.5-10.5 mg/dL. When serum calcium levels drop below 8.5 mg/dL,
the parathyroid gland responds by releasing parathyroid hormone (PTH), which triggers
a number of processes that help restore serum calcium level back to normal. PTH
results in the activation of the renal 1α-hydroxylase, subsequently increasing the
production of calcitriol from 25-hydroxyvitamin D. Calcitriol then increases absorption of
calcium from small intestine, increases bone resorption by activation of osteoclasts, and
increases renal calcium re-absorption (Holick, 2004).

Calcitriol works in several ways to increase serum calcium concentrations to
normal levels. Calcitriol:
— binds to VDRs on intestinal enterocytes. It increases expression of epithelial
calcium channels and increases synthesis of calbindin and other proteins, which will
facilitate calcium transport across the enterocyte into the circulation (Holick, 2004).
— similarly binds to VDRs on renal cells to reduce renal calcium excretion.
— works with PTH to cause an increase in bone resorption. Calcitriol binds to
VDRs expressed in osteoblasts, causing them to release factors that lead to the
differentiation of precursor cells into mature osteoclasts. As osteoclasts break down
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bone by releasing hydrochloric acid and collagenase, calcium is freed from
hydroxyapatite, the bone mineral complex, and released into the circulation (Holick,
2004).

The metabolic responses to prolonged vitamin D deficiency result in increased
bone resorption and skeletal weakening.

Nonskeletal function
Recent research has identified numerous tissues, including immune cells, colon,
placenta, breast, prostate, pancreas and the skin, that express the 1α-hydroxylase
enzyme and are therefore capable of producing calcitriol (Martini & Wood, 2006). The
VDR has also been identified in a number of cells and organs, such as activated T cells
and B cells, β-islet cells, and cells in the prostate, breast, colon, and other organs (Holick,
2004a). These new discoveries shed light on the nonskeletal functions of vitamin D, in
which it acts as an autocrine and paracrine hormone.

Cell proliferation and differentiation in relation to cancer
Since the 1980s, evidence from various cell lines has demonstrated that vitamin
D may protect against various cancers, including colon, prostate and breast (Holick,
2008c;Holick 2006). Many epidemiologic studies have also shown a strong inverse
relation between exposure to sunlight and the incidence of certain types of cancer.
Tanaka et al. (1982) found that calcitriol at concentrations of 0.12 nmol/L and above
inhibited the proliferation of human leukemic cells by 50% and induced their
differentiation into mature granulocytes. Since then, the anti-proliferative effect of
calcitriol has been confirmed in many other cell types (Trump, 2004.). Investigators
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found that calcitriol works through both autocrine and pararcrine mechanisms to inhibit
proliferation and induce differentiation of normal and some types of cancerous cells
(Holick, 2004a).

Based on these findings, researchers hypothesized that calcitriol may have antitumorigenic properties and that calcitriol and its analogues could be useful in treatment
of cancer. However, tumors develop several different ways to prevent antiproliferative
activity of calcitriol. For example, some human prostate cancer cells can up- regulate the
24-hydroxylase, which degrades of calcitriol, thereby inhibiting the effects of calcitriol on
proliferation and differentiation. (Chen and Holick, 2003)

Heart disease
In 1997, Rostand (1997) first reported that living at ahigh latitude correlated with
hypertension. Hypertensive patients exposed to UVB had lower systolic and diastolic
blood pressure, which was also accompanied by a 180% increase in 25 (OH) D levels.
The mechanism supporting this observation was provided by Li et al (2002). They found
calcitriol may suppress renin in a mouse model. Renin is an enzyme that triggers a
series of events that result in the production of angiotensin II, which increases blood
pressure. This may help to explain the antihypertensive function of vitamin D.

Other studies reported that vitamin D deficiency increases the risk of developing
type 2 diabetes (Carbone, 2007), which can exacerbate lipoprotein disorders and
increase the risk of cardiovascular diseases. Moreover, Wang et al. (2008) reported that
vitamin D deficiency was associated with a 50% increase in the risk of dying from
myocardial infarction. Therefore, it is possible that vitamin D deficiency contributes to
CVD through its association with risk factors, such as diabetes and hypertension.
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Direct effects of vitamin D on the cardiovascular system may also be involved.
The VDR is expressed in cardiomyocytes, vascular smooth muscle cells and endothelial
cells, and vitamin D has been shown to affect inflammation, cell proliferation and
differentiation, which also contribute to heart disease, although the precise relationship
has not been described.

Diabetes
The presence of 1α-hydroxylase in the pancreas and the expression of the VDR
in pancreatic β-cells suggests that calcitriol may be involved in the insulin response. In a
study conducted in 51 regions worldwide, researchers showed a relationship between
vitamin D deficiency and increased risk of developing type 1diabetes (Mohr, 2008).
Furthermore, higher vitamin D intake in early childhood may be associated with
decreased risk of developing type 1 diabetes mellitus (Holick, 2008b). Ayesha et al
(2001) also found vitamin D deficiency reduces insulin secretion and turnover in rats.

Autoimmune diseases
Resting T cells and B cells do not express the VDR, but VDR is expressed in
activated B cell, T cells and macrophages, which suggests that vitamin D is involved in
immune system regulation on some level (Van and Mathieu, 2005)

Multiple sclerosis, Crohn‘s disease, inflammatory bowel disease, and ulcerative
colitis are all autoimmune diseases. Epidemiologic evidence suggests that these
conditions may be related to vitamin D deficiency (Holick, 2004; Sentongo, 2001)
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Infection and inflammation
The immune system is responsible for protecting the host from infection. There
are two main divisions of the immune system: innate immunity, which provides an
immediate, but non-specific response to foreign substances; and adaptive immunity,
which is activated after the innate response is initiated. Vitamin D is involved primarily
with innate immunity, which includes the production of antimicrobial peptides, such as Bdefensins and cathelicidins, which are capable of killing viruses, bacteria and fungi.
These two particular peptides are produced by epithelial surfaces and within circulating
leukocytes (Adams, 2002). Human cathelicidin antimicrobial protein hCAP18, which is
the sole cathelicidin protein in humans, is encoded by CAMP. Liu et al (2006) found that
hCAP18 is a multifunctional protein with receptor –mediated vitamin D-dependent effects.
(Gombart, 2009)

The expression of VDR and the 1-α- hydroxylase gene is up-regulated when
receptors in human macrophages are activated, which increases the amount of 1,
25(OH) D in the cell. Thus, calcitriol is able to interact with the promoter region on the
cathelicidin gene, enhancing hCAP-18 production and subsequent pathogen destruction.
This mechanism has also been demonstrated in myeloid cells (Gombart, 2005),
bronchial epithelial cells (Yim, 2007) and keratinocytes ( Weber ,2005). Weber found
that 25(OH) D could also induce intracellular hCAP-18 through autocrine induction of the
1-α- hydroxylase enzyme.

Liu et al ( 2006) observed that cathelicidin messenger RNA induction is lower in
African-American individuals, who are known to have increased susceptibility to
tuberculosis (Matsuoka, 1991) and are more likely to have low 25-hydroxyvitamin D
status (Stead, 1990). Differences in the ability of human populations to produce vitamin
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D may contribute to susceptibility to microbial infection and inflammatory processes. The
relationship between vitamin D status and immune function may help to explain the
reported association between vitamin D status and asthma.

Vitamin D also has functions in the adaptive immune system. VDR was found to
be expressed in activated T and B lymphocytes. (Bhalla, 1983) 1, 25(OH) D suppresses
T helper cell proliferation and modulates their cytokine production such as IL-2 ,
IL10.( Lemire, 1985). It was also found that 1, 25(OH) D has the ability to inhibit TH 1
cytokines production (Lemire, 1995) and enhance TH 2 cytokines (Boonstra, 2001), but
it suggested that high levels of vitamin D would be associated with asthma, the opposite
function in compare with vitamin function in the innate immune system

Intake Recommendations
The Food and Nutrition Board (FNB) established Adequate Intake levels (AI) for
vitamin D that represent a daily intake that is thought to be sufficient to maintain bone
health and normal calcium metabolism in healthy persons. The AI for Vitamin D for
different ages, which was established in 1997, is shown in Table 3-2.
Table3-2: Adequate Intakes (AIs) for Vitamin D
Age
Birth to 13
years
14-18 years
19-50 years
51-70 years
71+ years

Children
5 mcg
(200 IU)

Men

5 mcg
(200 IU)
5 mcg
(200 IU)
10 mcg
(400 IU)
15 mcg
(600 IU)

Women

5 mcg
(200 IU)
5 mcg
(200 IU)
10 mcg
(400 IU)
15 mcg
(600 IU)
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Pregnancy

5 mcg
(200 IU)
5 mcg
(200 IU)

Lactation

5 mcg
(200 IU)
5 mcg
(200 IU)

In October of 2008, the American Academy of Pediatrics released new guidelines
concerning vitamin D for infants, children and adolescents that doubled the
recommended minimum intake of vitamin D from 200 international units (IU) to 400 IU
per day because medical conditions attributable to low vitamin D levels appear to be on
the rise in the U.S. The FNB also established an expert committee in 2008 to review the
DRIs for vitamin D. In recent years, many vitamin D experts have indicated that current
AI for vitamin D intake is too low, suggesting that the amount should be increased to
1000 IU/day to raise serum vitamin D to optimal levels (Tangpricha et al.2003) The FNB
expects to issue its report, updating as appropriate the DRIs for vitamin D in 2010.

Assessment of Vitamin D Status
Vitamin D status in the body is assessed by the measuring circulating levels of
25(OH)D3 . The traditional deficiency values were defined by The Institute of Medicine in
1997s as less than 27.5 nmol/L in children and less than 37.5 nmol/L in adults. However,
many scientists have suggested that the criteria used to define deficiency status should
be revised since these levels were set based on adequate amounts to prevent rickets in
children and osteomalacia in adults, and not the nonskeletal functions of vitamin D, such
as its role in cancer, autoimmunity and heart disease (Heaney, 2003). Because vitamin
D plays a central role in calcium homeostasis and skeletal health, most researchers
agreed that optimal range of circulating 25(OH)D3 should be the range that reduces PTH
levels to a minimum and maximizes calcium absorption (Dawson-Hughes et al. 2005).
Several studies have shown that circulating 25(OH)D3 levels of approximately 75 nmol/L
are sufficient to optimize vitamin D status. (Chapuy, 1997; Holick, 2005,Heaney, 2003).
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Vitamin D deficiency
Because humans can synthesize vitamin D from sun exposure, the potential for
widespread deficiency was previously thought to be quite small. However, recent studies
have begun to reveal the unrecognized high prevalence of vitamin D deficiency in many
populations worldwide (Ginde, 2009;Gordon, 2004; Looker, 2002; Kinyamu, 1997;
Chapuy, 1997). Vitamin D inadequacy and deficiency are reported in a wide variety of
apparently healthy populations, including children, adolescents, young adults, and
middle-aged and elderly adults. Dark-skinned and older persons are at the highest risk
of deficiency because pigment in dark skin reduces the amount of UVB that reaches 7dehydrocholesterol and the level of 7-dehydrocholesterol in the skin declines with age
(Holick, 2004a).

The reasons for widespread vitamin D deficiency are not completely understood,
but researchers believe that changes in lifestyle play an important role. Most people do
not spend sufficient time in the sun without wearing sunscreen to produce enough
vitamin D. In addition, as discussed previously, few foods are naturally rich in vitamin D
and only a handful of foods are fortified, so dietary intake of the vitamin is frequently
inadequate.

Prolonged vitamin D deficiency decreases calcium absorption, leading to bone
abnormalities, such as rickets in children and osteomalacia in adults. (Lips, 2001).
Rickets is characterized by softening and weakening of bones, leading to bowed legs,
knocked knees and rib bone malformation. The prevalence of rickets was extremely high
in the nineteenth century due to industrialization and child labor practices that frequently
limited sun exposure. Although rickets is rare in developed countries, numerous cases
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have been reported in exclusively breastfed infants, particularly African-Americans, and
the condition continues to be a problem in developing countries. Osteomalacia is a
similar condition that occurs in adults and contributes to fractures. (Thacher et al., 2006)
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CHAPTER 4

VITAMIN D AND ASTHMA

The possible relationship between asthma and vitamin D deficiency was first put
forward by Litonjua and Weiss in 2007. It is a new area of research, and few studies
have examined the potential relationship, but results from these studies provide
evidence that vitamin D status may influence the risk of developing asthma (Camargo,
2007; Devereux, 2007; Erkkola 2009; Camargo, 2006; Hypponen, 2004; Gale, 2007).

Innate Immunity, Infection and Vitamin D
Human infections are caused by viruses, bacteria, and fungi. When potential
pathogens enter in the body, the innate immune system is designed to recognize nonspecific pathogen associated molecular patterns (PAMP‘s). The vast majority of
microorganisms are destroyed within minutes or hours by innate defenses. The adaptive
immune response comes into play only with specific signaling of the innate immune
system. Innate immunity, therefore, is the first line of defense against infection (Fleer,
2007). Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate
immune system. They are single membrane-spanning, non-catalytic receptors that
recognize structurally conserved molecules derived from microbes. Once these
microbes have breached physical barriers, such as the skin, lung epithelial surface or
intestinal mucosa, they are recognized by TLRs, which activates immune cell responses
(Hewison, 2008). Human cathelicidin antimicrobial protein hCAP18 is one of the TLR
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proteins in the innate immune system, and it is expressed in epithelial cells of the human
lung (Bals, 1998). Immunohistochemistry has demonstrated that, in addition to bronchial
epithelial cells, hCAP18 is located in alveolar macrophages and bronchial glands
(Agerberth, 1999). This important antimicrobial peptide is mediated by vitamin D.

Liu et al (2006) found that hCAP18 is has receptor–mediated vitamin Ddependent effects. The expression of the VDR and 1-α-hydroxylase genes is upregulated when receptors in human macrophages are activated, which increases the
amount of 1, 25(OH) D in the cell. Thus, locally produced calcitriol is able to interact with
the promoter region on the cathelicidin gene, enhancing hCAP-18 production and
subsequent ability to recognize pathogens. This mechanism has also been
demonstrated in bronchial epithelial cells (Yim, 2007). Pathogens would be largely
decreased through the action of hCAP-18.

Studies Examining Vitamin D and Asthma
Litonjua and Weiss first suggested that vitamin D deficiency in pregnant women
and their offspring could at least partly explain the current rise in incident asthma.
(Moorman, 2007) Although subsequent epidemiologic studies provided additional
support for an association between vitamin D status and asthma, study results have
been inconsistent, with some evidence suggesting no association and others even
suggesting that vitamin D might be detrimental.

A large cross-sectional study from the Third National Health and Nutrition
Examination Survey in U.S. reported that vitamin D intakes and serum levels of 25 (OH)
vitamin D were associated with lung function in adults (Black, 2005). Similar findings
have been reported in Australian adolescents (Burns, 2006). In addition, an association
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between low maternal intakes of vitamin D during pregnancy and early childhood
wheezing has been reported in studies in the United States (Camargo, 2007) and
Scotland (Devereux, 2007). Both studies had a large sample size (over 1000 pregnant
participants) and showed that the risk of wheeze was more than 50% lower in offspring
whose mother had higher vitamin D intake compared to those whose mothers had lower
intake. However, although the Scottish study (Devereux, 2007) reported an association
between low vitamin D intake and increased risk of respiratory infections and childhood
wheezing, no association was observed between vitamin D intake and asthma
diagnosed at the age 5. This finding is in contrast to the results of another recent birth
cohort study, conducted in Finland among 1669 mother and child pairs (Erkkola 2009),
which found that higher maternal vitamin D intake during pregnancy was associated with
a reduced risk of asthma in 5-year-old children.

An important weakness in these studies is that they all relied solely on food
frequency assessment of vitamin D intake as their measure of vitamin D status; none of
the studies measured serum 25 (OH) D level, which is a much more reliable measure of
vitamin D status. Dietary vitamin D intake is actually poorly correlated with serum levels
of 25-OH D, which is influenced by many non-dietary factors, such as skin pigmentation,
latitude and the extent of sun exposure. Although these studies raise the possibility that
dietary vitamin D intake may influence the risk of developing asthma, it is also possible
that the observed associations may be confounded by other components in vitamin Drich foods, such as omega-3 fatty acids, that may impact airway reactivity (Reisman et
al., 2006). In addition, persons with asthma may adopt certain lifestyle characteristics,
such as avoiding outdoor exercise and milk intake (Camargo, 2007), that could influence
the occurrence of asthma or estimates of vitamin D intake. One study that did measure
25(OH) vitamin D also reported inconsistent findings. In a birth cohort study, conducted
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among 922 infants in New Zealand (Camargo, 2008), low cord blood levels of 25(OH) D
levels were associated with increased respiratory infections and childhood wheezing but
not with asthma diagnosed at age 5.

In addition to studies suggesting that vitamin D may protect against asthma or
have no effect, a few studies have actually reported that vitamin D might increase
asthma risk. Hypponen et al. (2004) reported that regular vitamin D supplementation (≥
2000 IU/d) in the first year of life increased the risk of developing asthma by age 31
years (Hypponen, 2004). However, this study did not assess maternal vitamin D intake
nor did it measure serum 25(OH) vitamin D levels in the subjects and their mothers.
Therefore, we do not know whether the vitamin D supplementation increased the asthma
risk or if the infant‘s asthma risk was influenced by maternal vitamin D status during
pregnancy. It is also possible that the long follow-up period contributed to recall bias,
which could affect estimates of the association. Another prospective study, conducted
among 466 pregnant women in the United Kingdom, also reported that high 25(OH)vitamin D concentration in the peripheral circulation during late pregnancy was
associated with an increased risk of eczema at 9 months and asthma at age 9 years
(Gale, 2007). A weakness of this study is that it had a large loss to follow up, with only
30% of the participants retained at the end, and it is possible that the vitamin D status or
occurrence of asthma differed between those who were lost to follow up and those who
completed the study. These studies suggest that maternal supplemental vitamin D and
high serum vitamin D concentrations may somehow increase the risk of developing
asthma in their offspring (Wjst, 2006).

In addition to the development of asthma, some researchers have focused on
examining the relationship between vitamin D and asthma severity in persons already
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diagnosed with asthma. Two studies involving a childhood asthma management
program in the United States (Ciaccio,2010; Brehm, 2010) and one cross-sectional study
in Costa Rica ( Brehm, 2009) all suggested that vitamin D insufficiency [serum 25(OH) D
<75 nmol/L] was common in children with severe asthma. One limitation of these studies
is that none of them had data on respiratory tract infections. It is possible that vitamin D
may work indirectly by helping to prevent respiratory tract infections rather than by
modifying airway inflammation. However, Xystrakis et al (2006) reported in that vitamin
D may enhance glucocorticoid responsiveness by increasing IL-10 production, which
suggests that vitamin D may help to ameliorate the inflammatory symptoms associated
with asthma. The inconsistency of the findings from these studies underscores the need
for further research in this area to clarify the association between vitamin D status and
asthma.
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CHAPTER 5

PURPOSE OF THE STUDY

Asthma is a common condition throughout the world, contributing to both
morbidity and healthcare costs. Vitamin D deficiency is also a world health problem, and
recent evidence suggests that the two conditions may be related, although the data
supporting an association are inconsistent and contradictory.

The main objective of this research project is to assess the relationship between
measures of vitamin D status and self-reported wheeze and asthma in a cohort of young,
healthy women who participated in the UMass Vitamin D Status Study.

Hypotheses and Specific Aims
Hypotheses
1. Higher serum 25(OH)D3 concentration will be associated with reduced risk of wheeze
and asthma.
2. Higher dietary intake of vitamin D will be associated with reduced risk of wheeze and
asthma.
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Specific aims
1. Determine the prevalence of suboptimal vitamin D status and vitamin Deficiency
among subjects by measuring serum concentrations of 25 (OH) vitamins D.
2. Assess the relationship between dietary intake of vitamin D and other nutrients and
self-reported wheeze and asthma.
3. Assess the relationship between serum concentrations of 25(OH) vitamin D and selfreported wheeze and asthma.
4. Identify the predictors of serum 25 (OH) D in this specific sample.
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CHAPTER 6

MATERIALS AND METHODS

Study Subjects
The current analyses use data obtained from the University of Massachusetts
Vitamin D Status Study, a cross-sectional study conducted by researchers at the
University of Massachusetts. The current study includes 186 women between the ages
of 18 and 30, mostly from UMass Amherst campus and surrounding community, who
were voluntarily enrolled in the study between 2006 and 2008. Amherst is located in
Western Massachusetts (latitude, 42.37N and longitude, -72.53W ). Women were
excluded from the main study if they were pregnant and/or had any serious chronic
diseases, such as heart disease or diabetes, or were currently taking any of the following
medications: corticosteroids, anabolic steroids, anticonvulsants, propranolol and
cimetidine.

Data Collection
Collection of dietary and demographic data
Each participant completed a single 2-hour clinic visit, which was scheduled
during the late lacteal phase of her menstrual cycle, three to five days before the
expected start of the next menstrual period. At that visit, women completed a previously
validated Harvard Food Frequency Questionnaire (Willett, 1985) and a questionnaire
designed specifically for this study to elicit demographic and health-related data.
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The FFQ asked about common food sources of vitamin D (fortified milk and fatty
fish) as well as foods that may or may not contain the vitamin, depending on the
manufacturer‘s fortification practices (yogurt, cheese, breakfast cereals, fruit juices). The
Harvard FFQ was adapted for this study to inquire about food intake in the previous two
months.

Measurements
Height, weight and waist circumference were measured during the clinical visit.
Height was measured to the nearest 0.5 centimeter; weight in light clothing was
measured to the nearest 0.1 kilogram. Waist circumference was measured to the
nearest 0.5 inch. Body mass index (BMI) was calculated as weight (kg)/[height (m)]2. A
dual x-ray absorptiometry (DXA) scan was performed by the same trained technician to
determine body composition, including percent body fat. Fasting venous blood samples
were obtained by a trained phlebotomist. Blood samples were kept on ice for up to two
hours prior to centrifugation and separation into serum and plasma fractions. Serum and
plasma were stored at -80ºC until assayed. Serum concentration of 25(OH) vitamin D
was measured in the laboratory of Dr. Alayne Ronnenberg using a commercially
available radioimmunoassay kit (Diasorin, MN). The coefficient of variation for this assay
in the Ronnenberg lab varied from 8 to 13%. Final determination of 25(OH) vitamin D
concentrations were calculated using GraphPad Prism version 4.00 for Windows
(GraphPad Software, San Diego California, USA).

Respiratory symptom data collection
As part of the health questionnaire, subjects responded to a battery of questions
designed to elicit information on respiratory symptoms, including wheeze and the
diagnosis of asthma. These questions were derived from previously validated
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international study of asthma and allergies in childhood study questionnaire. The
questionnaire also ascertained whether the participant had eczema, a condition often
associated with asthma.

Statistical Analysis
The statistical analysis will be carried out using SAS version 9.2. Descriptive data
are summarized using mean ± standard deviations, median, range and percentages.
Logarithmic transformation was used to improve normality for variables that were not
normally distributed. Statistical significance is set at p≤ 0.05.

Main exposure and outcome variables
The main outcome measures were self-reported wheeze and self-reported
asthma, both of which were modeled as dichotomous (yes/no) variables. A secondary
outcome measure was serum concentration of 25(OH) vitamin D, which was modeled as
a continuous variable, a categorical variable (deficient, suboptimal, optimal), and a
dichotomous variable (insufficient, sufficient), depending on the specific analysis. The
main exposure variables were indicators of vitamin D status—both energy-adjusted
dietary intake of vitamin D, modeled as both a continuous and a dichotomous (below
AI/at or above AI) variable, and serum 25(OH) vitamin D concentration, also modeled as
both a continuous variable and a categorical (deficient, suboptimal, optimal) variable.

Covariates
The main covariates of interest include BMI, percent body fat, age, and smoking
history. Other covariates considered for inclusion in final models include sun exposure,
season of blood draw, oral contraceptive (OC) use, activity level, and numerous dietary
factors, including intake of vitamins C and E and omega-3 fatty acids.
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Statistical tests
Chi-Square tests for equivalence of proportions and t-tests for equality of means
were used to assess the relationship between covariates and asthma/wheeze and the
relationship between covariates and measures of vitamin D status (dietary intake and
serum concentration of 25(OH) vitamin D). To achieve the second and third study aims,
which are to assess the relationship between dietary intake of vitamin D, serum 25(OH)
D and other nutrients and self-reported wheeze and asthma, simple logistic regression
was used first to calculate a crude prevalence odds ratio (POR) and 95% confidence
interval (CI) between dietary intake of vitamin D and other nutrients and asthma and
wheeze. For each univariable logistic model, variables with a p value of ≤ 0.25 were
entered into multiple logistic regression models. Final models describing each of the
relationships include covariates that are significant at the p≤ 0.10 level as well as other
variables, such as BMI and smoking status, which may be considered important
components of the model. The results of multiple logistic regressions are expressed as
odds ratios (OR) with 95% CI.

Linear regression was used to identify the predictors of serum 25(OH)D in our
sample. Simple linear regression was used to identify potential predictors; variables that
were associated with vitamin D at the level of p ≤ 0.25 were included in multivariable
linear regression models. The criteria for variable inclusion in the final regression model
was similar to that used for multiple logistic regression, described above.
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CHAPTER 7

RESULTS

There were 186 women enrolled in the study, most of whom (85.5%) were white
(Table 7.1). The mean age was 21.5 (SD=3.2) years and the mean BMI was 23 kg/m 2.
Mean dietary intakes of vitamin D and energy were 375 IU and 2187 kcal, respectively.

Characteristics of study participants based on optimal ( ≥75nmol/L n=84) versus
suboptimal (< 75nmol/L n=102) serum levels of 25-OH vitamin D are also included in
Table 7.1. Although the mean (± SD) levels of most covariates did not differ by vitamin D
status, dietary vitamin D intake was significantly greater (p =0.04) in the group with
optimal vitamin D status than in the group with suboptimal serum levels of 25-OH vitamin
D. A total of 82 participants reported having experienced wheeze or asthma symptoms
in the past 12 month. Of these, 37(45%) had suboptimal serum 25(OH) D and 45(55%)
had optimal vitamin D status. The proportion of women with suboptimal vitamin D status
differed significantly according to sun exposure (p<0.02) and race (p< 0.01).

Characteristics of the study sample based on wheeze/asthma symptoms are
shown in Table 7.2. Older, more active women and those with lower serum 25(OH) D
levels reported fewer wheeze/asthma symptoms. In addition, the group with
asthma/wheeze symptoms had significantly higher serum 25(OH) D status (p=0.02) than
women without symptoms. The proportion of women who had low dietary vitamin D
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intake, short time (≤ 2 hours) spent outside in minimal clothing and high hs-CRP level
were significantly higher in women with symptoms than in those without.
Table 7.1 Distribution of participant characteristics by serum 25(OH)D
Total

Variable

n=186

Serum
vitamin D
status
suboptimal
n=102

Serum
vitamin D
status
optimal
n=84

p1
value

Mean (SD)

Mean (SD)

Mean (SD)

Age( years)
2
BMI（kg/m ）

21.5(3.2)
23.0(3.2)

21.8(3.4)
23.1(3.3)

21.3(2.9)
23.0(2.9)

0.32
0.76

Body Fat (%)

31.9(7.9)

32.4(8.1)
n=97

31.3(7,7)
n=80

0.35

9.0(3.6)

9.4(3.7)

8.6(3.3)

0.21

Vitamin D ( IU)

375(269)

338(234)

421(303)

0.04

Vitamin C (mg)

208(180)

209(157)

206(205)

0.92

Vitamin E (mg)

18.4(29.9)

18.0(34.1)

18.9(24.1)

0.83

0.3(0.3)

0.3(0.3)

0.3(0.3)

0.72

Calcium (diet; mg)

1018(475)

1029(483)

1005(466)

0.74

Total Energy (Cal)

2187(785)

2187(808)

2187(761)

1

Physical Activity
2
(MET /week)
Dietary intake

Omega-3 (g)

n (%)

n (%)

Vitamin D (< 200 IU)

54 (29.0)

34 (63)

20 (37)

0.15

Vitamin C (< 60 mg)

8(4.3)
n=168

7(88)

1(12)

0.08

Vitamin E (< 15 mg)

110(59.2)

68(62)

42(38)

0.02

Vitamin Intake by DRI

n (%)

3

0.79

BMI
2

140(75.3)

76(54)

64(46)

2

>25 (kg/m )

46(24.7)

26(57)

20(43)

hs CRP ≥3 mg/L

49(26.3)

20(41)

29(59)

≤25 (kg/m )

Respiratory symptom

0.02
0.02

Wheeze or asthma

82(44.1)

37(45)

45(55)

No symptom

104(55.9)

65(63)

39(37 )
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Table 7.1, Continued

Variable

Total
n=186
n(%)

Serum
vitamin D
status
suboptimal

Serum
vitamin D
status
optimal

n=102

n=84

n (%)

p- value

n (%)

Race

0.01

White

159(85.5)

81(51)

78(49)

Non-white

27(14.5)

21(78)

6(22)

Some college

150(80.7)

78(52)

72(48)

College graduate

36(19.3)

24(67)

12(33)

Education

0.11

Smoking Status
Ever/current smoker

0.91
26(14.0)

14(54)

12(46)

Non- smoker

160(86.0)

88(55)

72(45)

Current oral
contraceptives use

73(39.3)

26(36)

47(64)

Hours outdoors in past
week

0.16

≤ 2 hours

156(83.9)

89(57)

67(43)

≥ 3 hours

30(16.1)

13(43)

17(57)

No sunscreen use
Month of blood draw
High sun exposure
3
month (4,5,9,10)

76(40.9)

38(50)

38(50)

Low sun exposure
month(1,2,3,11,12)

<0.0001

0.27
0.02

99

46(46)

54(54)

84

54(64)

30(36)

1. Statistical significance was assessed using t-test for continuous variables and chi-squarer analysis for categorical
variables
2. MET: Metabolic Equivalent, a unit used to estimate the amount of oxygen used by the body during physical activity.
3. DRI: Dietary Recommended Intakes (AI and RDA) for women in this age range. The AI for vitamin D =200IU; the RDA
for vitamin C=60mg, vitamin E=15mg
4. No participants was draw the blood in summer break( June, July, August)
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Table 7. 2 Distribution of participant characteristics by wheeze/asthma symptoms

Total

Variable

Wheeze/asthma
symptoms

No symptoms

n=82

n=104

n=186
Mean (SD)

Mean (SD)

p- value

Mean (SD)

Age( years)

21.5(3.2)

20.9( 2.2)

22.0(3.8)

0.02

2

BMI（kg/m ）

23.0(3.2)

23.4(2.9)

22.8(3.3)

0.19

Body Fat (%)

31.9(7.9)

33.1(6.9) (n=78)

Physical Activity
1
(MET /week)

9.0(3.6)

8.4(2.5)

9.5(4.3)

0.02

Serum 25(OH)D

79.3(31.8)

85.7(33.2)

74.0(29.8)n=100

0.01

Vitamin D ( IU)

375(269)

349.3(277.1)

396.0(262.7)

0.24

Vitamin C (mg)

208(180)

224.2(223.6)

194.9(135.4)

0.30

Vitamin E (mg)

18.4(29.9)

17.6(24.5)

19.1(33.7)

0.74

Omega-3 (g)

0.30(0.30)

0.30(0.30)

0.30(0.30)

0.44

Calcium,
no supplement (mg)

1018(475)

1029(533)

1010(425)

0.79

Total Energy (kcal)

2187(785)

2279(866)

2115(711)

0.15

n (%)

n (%)

n (%)

Vitamin D suboptimal

54(29.0)

31(57)

23(43)

0.02

Vitamin C suboptimal

8(4.3) n=168

5(63)

3(37)

0.28

Vitamin E suboptimal

110(59.2)

48(44)

62(56)

0.88

31.0(8.5)
(n=99)

0.07

Dietary intake

Dietary frequency by DRI

2

BMI

0.44
2

140(75.3)

64(46)

76(54)

2

46(24.7)

18(39)

28(61)

49(26.3)

27(55)

22(45)

<75nmol/L

102(54.9)

37(36)

65(64)

≥75nmol/L

84(45.2)

45(54)

39(46)

≤25 (kg/m )
>25 (kg/m )
hs CRP>3 mg/L
Vitamin D status 25(OH)D

Race

0.07
0.02

0.96

White

159(85.5)

70(44)

89(56)

Non-white

21(14.5)

12(44)

15(56)
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Table 7.2 continued

Variable

Total
n=186
n (%)

Wheeze/asthma
symptoms

No
symptoms

n=82

n=104

n (%)

p- value

n (%)

Time outdoors in past week
≤ 2 hours
≥ 3 hours

156(83.9)
30(16.1)

62(40)
20(67)

94(60)
10(33)

No sunscreen use

76(40.9)

31(41)

45(59)

0.007

Education
Some college
College graduate
Smoking Status
Ever/current smoker
Non- smoker
Current oral contraceptives use

0.45
0.15

150(80.7)
36(19.3)

70(47)
12(33)

80(53)
24(67)

26(14.0)

13(50)

13(50)

160(86.0)

69(43)

91(57)

73(39.3)

36(49)

37(51)

0.51

0.25

1. MET: Metabolic Equivalent, a unit used to estimate the amount of oxygen used by the body during physical activity.
2. DRI: Dietary Reference Intake (includes adequate intake, AI, and recommended dietary allowance, RDA.
The AI for vitamin D =200 IU; the RDAs for vitamin C=60mg and vitamin E=15mg

Univariable logistic regression was used to assess the relationship between
wheeze/ asthma symptoms and each exposure variable (Table 7.3). Physical activity
level, in Metabolic Equivalents (METS; used to estimate the amount of oxygen
consumed during physical activity) and total energy intake were divided into quartiles.
Suboptimal serum 25(OH)D status, short time (≤ 2 hours) daily spent outside and high
physical activity (the highest quartiles of physical activity level) were significantly
associated with reduced risk of wheeze/asthma symptoms (p<0.05), whereas low dietary
vitamin D and high hs-CRP were associated with increased risk of symptoms (p =0.02
and 0.07, respectively).
Variables with p ≤0.25 in univariable models as well as BMI, energy intake and
smoking status, which were considered important components of the model for
physiologic reasons, were entered into a multivariable logistic regression model. (Model
1, Table 7.4). After adjusting for other covariates, all previously significant variables
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except physical activity remained significantly associated with wheeze/asthma (p <0.1;
Model 2) and were entered into Model 3. Controlling for energy, BMI, smoking and age
(Model 4) did not substantially alter OR estimates or the level of statistical significance.
Table 7.3 Univariable Logistic Regression by Wheeze/Asthma Symptoms
Variable

Unadjusted OR (95%)

p- value
0.15

Education
Some college
College graduate

1.75(0.82,3.76)
1

2

BMI（kg/m ）

0.44

2

1

2

0.76(0.39,1.51)

≤25 (kg/m )
>25 (kg/m )
Body Fat (%)
≤32

1

>32

1.05(0.59,1.87)

0.88

Physical Activity
1
3
(MET /week)
Quartile 1

1

1

Quartile 2

1.14(0.51,2.59)

Quartile 3

1.55(0.68,3.52)

0.65
0.10

Quartile 4

0.61(0.26,1.42)

0.05

<75 nmol/l

0.49(0.27,0.89)

0.02

≥75 nmol/L

1

1

<200IU

2.14(1.13,4.07)

0.02

≥200IU

1
1.83(0.95,3.54)

1
0.07

≤ 2 hours

0.33(0.15,0.75)

0.008

≥ 3 hours

1

1

1.42(0.78,2.56)

0.24

Serum 25(OH) D

Dietary vitamin D

hs CRP>3 mg/L
Time outside

Current oral
contraceptives use
Energy Intake

3

Quartile 1

1

1

Quartile 2

1.38(0.60,3.16)

0.91

Quartile 3
Quartile 4

1.20(0.52,2.78)
1.94(0.85,4.44)

0.67
0.15

1. MET: Metabolic Equivalent, a unit used to estimate the amount of oxygen used by the body during physical activity.
2. RDA: Reference Daily Allowance .The RDA for vitamin D =200IU, vitamin C=60mg, vitamin E=15mg
3. Quartile 1: cut off lowest 25% of data, Quartile 2: cut data set in half, Quartile 3: cut at 75% of data, Quartile 4: cut off
highest 25% of data.
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Table 7.4 Multivariable Logistic Regression of wheeze/asthma symptom by selected covariates
Univariable

Variable
Low serum
25(OH)D
(<75nmol/l)
Low vitamin
intake(<200IU)
Hs_CRP
(>=3mg/l)
Time outside
<=2hours
High physical
activity
(Mets >10.13/we
ek)
Low education
level( some
college)
Current oral
contraceptives
user
High energy
intake
( >2614kcal)
High BMI
2
(>25kg/m )

1

OR
(95%CI)

pvalue

0.49
(0.27,0.89)

0.02

2.14
(1.13,4.07)
1.83
(0.95,3.54)
0.33
(0.15,0.75)

0.02
0.07
0.008

Model 1
OR
(95%CI)
0.48
(0.24,0.96)
3.35
(1.61,6.96)
2.06
(0.94,4.51)
0.28
(0.11,0.68)

pvalue
0.04
0.001
0.07
0.005

Model 2
OR
(95%CI)
0.45
(0.22,0.91)
3.63
(1.72,7.63)
1.97
(0.89,4.35)
0.30
(0.12,0.74)

Multivariable
Model 3
pOR
value
( 95%CI)
0.03
0.0007
0.1
0.009

0.50
(0.27,0.95)
2.93
(1.46,5.90)
2.06
(1.00,4.22)
0.27
(0.11,0.66)

pvalue
0.03
0.003
0.05
0.004

Model 4
OR
(95%CI)
0.52
(0.27,0.98)
3.13
(1.54,6.39)
1.96
(0.94,4.12)
0.29
(0.12,0.72)

pvalue
0.04
0.002
0.07
0.007

0.50
(0.25,1.01)

0.05

0.50
(0.19,1.34)

0.17

0.89
(0.28,2.89)

0.85

1.75
(0.82,3.76)

0.15

1.19
(0.41,3.48)

0.75

2.53
(0.63,10.18)

0.19

1.42
(0.78,2.56)

0.24

0.98
(0.47,2.05)

0.96

0.92
(0.44,1.94)

0.83

1.94
(0.85,4.44)

0.15

1.86
(0.89,3.93)

0.11

1.95
(0.91,4.15)

0.09

0.76
(0.39,1.51)

0.44

0.68
(0.32,1.47)

0.32

0.62
(0.29,1.35)

0.23

0.63
(0.30,1.35)

0.24

Ever and current
smoker

0.76
(0.33,1.74)

0.51

0.67
(0.26,1.72)

0.4

0.57
(0.21,1.52)

0.26

0.67
(0.26,1.72)

0.40

Age(years)

0.90
( 0.81, 0.99)

0.03

0.83
(0.66,1.03)

0.09

0.89
(0.80,1.00)

0.05

1.
2.
3.
4.
5.

Individual univariable logistic regression models with variable p<0.25 and some important components
Model 1: Multivariable logistic regression model with variable p<0.25 and some important components.
Model 2: adjust age for Multivariable logistic regression mode 1
Model 3: Multivariable logistic regression model with variable p<0.1 in model 2
Model 4: adjust age , BMI, smoking for multivariable logistic regression 3
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We used univariable linear regression to assess associations between exposure
variables and serum 25 (OH)D (Table 7.5). Dietary vitamin D, blood draw in a high sunexposure month, cold cereal and milk intake and current OC use were significantly
positively associated with serum 25 (OH) D, whereas BMI, sunscreen use and <2 hours
outside daily were negatively associated with 25(OH) D levels (p < 0.25). When these
variables were entered in multivariable linear regression models (Table 7.6, Models 2 &
3), four variables were significantly positively associated with vitamin D levels after
controlling for energy intake: dietary vitamin D, cold cereal intake, OC use and blood
draw in a high sun-exposure month; sunscreen use was negatively associated with
25(OH) D.
Table 7.5 Univariable linear regression of serum 25(OH) D by main factors
2

Coefficient

R

Dietary Vitamin D

0.02

0.04

0.006

BMI

-1.03

0.01

0.17

-0.0001

0.000003

0.98

Calcium without supplement
Omega 3

1.2

p-value

0.88

F205

-1.05

0.000016

0.96

F225

74.19

0.004

0.37

F226

3.58

0.0004

-7.21

0.012

0.78
0.13

Current oral contraceptive use

23.69

0.13

<.0001

Time outside (≤2hours)
Blood draw in high sun
1
exposure month
Food source

-9.08

0.01

0.15

10.67

0.17

0.03

Skim

4.81

0.0056

Milk

11.48

0.02

0.31
0.06

Egg

3.79

0.003

0.46

Liver

-6.73

0.0014

0.61

Sunscreen use

Tuna

0.02

0

1.0

Dkfish

-1.85

0.00085

Cold cereal intake

16.37

0.065

0.7
0.00005

Orange juice

0.84

0.0016

Multivitamins

7.7

0.015

1.

0.86
0.10

High sun exposure months include Apr, May, Sep, Oct. No blood was drawn in June, July or
August
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Table7. 6 Multivariable Linear Regression Model of Serum 25(OH)D by Selected
Covariables
Univariable

Multivariable
Model 1

1

Model 2

2

Coefficient

P-value

Coefficient

Pvalue

Coefficient

Pvalue

0.02

0.006

0.013

0.19

0.017

0.03

-1.03

0.17

-1.23

0.09

-1.27

0.07

Sunscreen use

-7.21

0.13

-9.26

0.04

-9.31

0.04

Oral contraceptive use

23.69

<.0001

-18.96

<.0001

19.34

<.0001

Milk

11.48

0.06

9.43

0.1

8.69

0.13

Cold cereal

16.37

0.00005

11.51

0.02

11.26

0.02

Blood draw in high sun
3
exposure month

10.67

0.03

-7.8

0.1

8.86

0.05

Time outside <=2hours

-9.08

0.15

-4.82

0.43

Multivitamin use

-7.70

0.1

-3.77

0.49

0.88

0.0002

0.95

-0.0003

0.93

Dietary vitamin D (IU)
2

BMI (kg/m )

Energy
1.
2.
3.

Model 1 multivariable linear regression model with variable p<0.25 and energy.
Model 2 multivariable linear regression model with variable p<0.1 in model 1 and energy.
High sun exposure month include Apr, May, Sep, Oct . No blood was drawn in June, July or August.
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CHAPTER 8

DISSUSION

The prevalence of asthma/wheeze (30.8%) observed in this cross-sectional study
is substantially higher than that reported for U.S. white non-Hispanic females (10.6%) or
all females (9.6%) in the same age range (NHIS data, 2007). The high prevalence we
observed may be due to misclassification of the outcome since wheeze/asthma status
was self-reported and was not confirmed by examination of medical records. The
relatively high number of wheeze/asthma ―cases‖ in the current study could influence
estimates of the association between exposure variables and asthma. Such
misclassification, however, would tend to bias our results toward the null.

We found that the risk of wheeze/asthma symptoms was three-times higher
among women with low dietary vitamin D intake (<200 IU/day) than in those with higher
dietary vitamin D. This observation is consistent with the findings of a birth cohort study
in which low maternal vitamin D intake was associated with increased risk of recurrent
wheezing in children. (Litonjua, 2007, Camargo, 2007; Devereux, 2007; Erkkola ,2009).

We hypothesized that high serum 25(OH) D would similarly be associated with
reduced risk of asthma/wheeze, but we found the opposite effect: after controlling for
vitamin D intake and other covariates, the risk of asthma/wheeze was 48% lower among
women with ―suboptimal‖ serum levels of 25(OH)D compared to women with optimal
vitamin D status. Although our findings were unexpected, they lend some support to
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previous observations by Gale et al.(2007), which found that high 25(OH) D
concentration in the peripheral circulation during late pregnancy was associated with
increased risk of eczema at 9 months and asthma at age 9 years. It is unclear whether
higher serum levels of 25(OH) are actually detrimental. We speculate that women in our
study who had higher serum levels of vitamin D likely spent more time outdoors, which
could have exposed them to more outdoor asthma/wheeze triggers.

The contradictory effects observed for dietary vitamin D and serum 25(OH)D are
not completely surprising since dietary vitamin D intake tends to be poorly correlated
with serum vitamin levels. For instance, although we found that dietary vitamin D was a
significant predictor of serum 25(OH) D (p=0.03), it only accounted for 4% of the
variability in serum 25(OH)D levels, suggesting that non-dietary factors also influenced
serum vitamin levels. In addition, it is possible that other dietary factors associated with
vitamin D-rich foods were responsible for the observed effect. However, we examined
possible food components, such as omega-3 fatty acids and calcium, and did not
observe an association between dietary intakes and wheeze/asthma symptoms for these
nutrients, although it remains possible that other, unevaluated food components play a
role.

Another possible explanation of the discrepancy is the low DRI for dietary vitamin
D (200 IU), which we used as our cut-off value for dietary adequacy. This level of intake
is insufficient to raise serum concentrations to the level considered ―optimal‖ by most
vitamin D experts. Had we raised the dietary cut-off to 600 IUs—the new RDA level
recently suggested by the Food and Nutrition Board – many more women would have
had ―suboptimal‖ intake, and the apparent risk associated with low intake may have
been attenuated.
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In addition to assessing the association between vitamin D status and
wheeze/asthma, our study also identified the predictors of serum 25 (OH) D in this
sample. In addition to total dietary vitamin D (p=0.03), intake of cold cereal (p=0.02) was
also predictive of serum 25(OH)D levels. Among non-dietary factors, month of blood
draw (p=0.05) and oral contraceptive use (p<0.0001) were positive predictors of serum
25(OH) D, and sunscreen use (p=0.04) was a negative predictor. Compared to other
vitamin D-rich foods, such as tuna or milk, cold cereal was the strongest dietary predictor
of serum vitamin D in our study, suggesting that vitamin D fortification is an important
contributor to dietary intake. The associations between serum vitamin D and month of
blood draw and sunscreen use are not surprising given the well-known major
contribution of cutaneous synthesis to vitamin D status. In addition, we found that, after
adjustment for covariates, oral contraceptive use was associated with 25(OH)D levels
that were on average 24 nmol/L greater than those observed in women who did not use
oral contraceptives. The positive association between oral contraceptive use and
25(OH)D levels has been described by others (Sowers et al., 1986; Harris and DawsonHughes, 1998); in fact, Harris and Dawson-Hughes (1998) reported the exact same
increment in 25(OH)D levels—24 nmol/L—that we observed in our study. Whether oral
contraceptive use actually improves vitamin D status is not known; however, other
researchers have speculated that the association it may be due to an estrogen-triggered
change in the relative proportions of free and protein-bound vitamin D (Harris and
Dawson-Hughes, 1998).

Strengths and Limitations
Our study has several important strengths. In addition to information on dietary
vitamin D intake and supplement use, we also had a biomarker measure of vitamin D
status. Most previous studies of asthma and vitamin D have only collected dietary
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vitamin D data. Given the generally poor correlation between dietary vitamin D intake
and serum levels, measuring serum concentration of 25(OH)D provides a more reliable
method for determining vitamin D status since it reflects circulating levels, which include
vitamin D derived both from diet and from cutaneous synthesis. In addition, our
collection of questionnaire data concerning lifestyle factors, such as time spent outdoors
and sunscreen use, helps to strengthen our analysis of predictors of 25(OH)D
concentration. And finally, our cohort was quite homogenous, consisting only of young,
healthy women with at least some college education. This homogeneity helps to reduce
confounding; however, it limits the generalizability of our findings.

Our study also had some limitations. First, the sample size was relatively small
(n=186). A larger sample size would have increased the statistical power to detect
associations. Secondly, because the study was originally intended to assess the
relationship between vitamin D status and premenstrual syndrome, women who routinely
use corticosteroids were ineligible. Because steroid use is common among persons with
more severe asthma, it is possible that we inadvertently excluded women with more
pronounced symptoms. Exclusion of these women would tend to bias our results toward
the null. Third, since nearly all participants were students on the UMass Amherst
campus, study activities were suspended during the summer months when most
students leave campus. It is possible that data collected during these high sun-exposure
months, when serum 25(OH)D levels are likely to be substantially higher, may have
altered our findings.

We found that dietary vitamin D intake less than 200 IU daily was associated with
an increased risk of asthma/wheeze symptoms. Other dietary components in vitamin Drich foods did not appear to influence asthma risk. In contrast, we found that the risk of
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wheeze/asthma symptoms was actually lower among women with ―suboptimal‖ serum
concentrations of 25(OH)D compared to women with apparently ―optimal‖ vitamin D
status. We doubt that higher serum levels of 25(OIH)D are an actual risk factor for
asthma. Rather, we speculate that women with higher serum vitamin D likely spent more
time outdoors during months that support cutaneous vitamin D synthesis and thereby
may have been exposed to allergens and other compounds that could trigger
asthma/wheeze symptoms. Because of the small sample size of the current study and
our inconsistent results, further studies using larger cohorts with more rigorous
assessment of asthma symptoms are needed to confirm our observations.
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